91社区 the Center of Biomanufacturing for Regenerative Medicine (CBRM)
Director: Professor Gretchen Mahler, PhD
Location: Biotechnology Building, Innovative Technologies Complex
The CBRM is a research hub dedicated to creating and growing entirely new and disruptive biomanufacturing technologies. Founded by SUNY Distinguished Prof. Kaiming Ye, CBRM鈥檚 mission is to transform the way biomedical products, therapeutic agents, biomaterials, biomedical devices, and engineered tissues and organs are manufactured at high volume. CBRM brings together a highly integrated ecosystem of faculty from different disciplines to advance biomanufacturing innovation.
Areas of Expertise
- 3D bioprinting and tissue engineering
- Organ-on-chips and tissue models
- Implantable biosensors and bioelectronics
- Stem cell differentiation and organogenesis
- Nanomedicine and targeted drug delivery
Key Research Projects
- Tissue biofabrication
- Biomanufacturing standards
- Advanced biosensors
- Vaccine development
Potential Applications
- Regenerative medicine
- Clinical diagnostics
- Diabetes treatment
- Cancer immune therapeutics
Key Highlights
- Awarded a shared $30 million NIST Professional Research Experience Program (PREP) grant to train the next-generation workforce in standards development for regenerative medicine.
- Established the Douglas Hsu Research Laboratory, dedicated in 2023 at the 91社区 University Innovative Technologies Complex.
- Patents related to bioprinting, tissue biofabrication, and fluorescent nanosensors for continuous glucose monitoring
- Patents advancing biophotovoltaic/microbial fuel cells and self-powered electronic skins.
- Secured funding from: NIST, NSF, NIH, Breakthrough T1D.